Frankfurt - Delayed Quote EUR

X4 Pharmaceuticals, Inc. (48Q.F)

Compare
0.6300
-0.2320
(-26.91%)
At close: January 31 at 8:09:03 AM GMT+1
All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-125,653.0000
-96,512.0000
-77,102.0000
-70,905.0000
-58,818.0000
Investing Cash Flow
70,778.0000
-14,883.0000
-103.0000
-615.0000
-1,362.0000
Financing Cash Flow
20,256.0000
88,516.0000
117,230.0000
74,245.0000
12,394.0000
End Cash Position
97,985.0000
100,248.0000
123,028.0000
83,108.0000
80,702.0000
Interest Paid Supplemental Data
--
4,604.0000
3,006.0000
2,906.0000
2,099.0000
Capital Expenditure
-7,320.0000
-60.0000
-103.0000
-615.0000
-1,362.0000
Issuance of Capital Stock
-8,456.0000
59,999.0000
122,631.0000
75,985.0000
--
Issuance of Debt
20,000.0000
22,500.0000
--
--
12,388.0000
Repayment of Debt
--
-2,064.0000
-795.0000
--
--
Repurchase of Capital Stock
--
--
--
-2,000.0000
-277.0000
Free Cash Flow
-132,973.0000
-96,572.0000
-77,205.0000
-71,520.0000
-60,180.0000
12/31/2020 - 2/14/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers